Published in Am J Physiol Lung Cell Mol Physiol on September 21, 2012
The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. Am J Physiol Lung Cell Mol Physiol (2014) 0.94
A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med (2015) 0.86
Fractalkine (CX3CL1) and its receptor CX3CR1 may contribute to increased angiogenesis in diabetic placenta. Mediators Inflamm (2013) 0.85
CX3CL1 (fractalkine) and TNFα production by perfused human placental lobules under normoxic and hypoxic conditions in vitro: the importance of CX3CR1 signaling. Inflamm Res (2013) 0.85
NADPH oxidases-do they play a role in TRPC regulation under hypoxia? Pflugers Arch (2015) 0.75
Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents. Mol Neurobiol (2016) 0.75
Lipopolysaccharide-Binding Protein Downregulates Fractalkine through Activation of p38 MAPK and NF-κB. Mediators Inflamm (2017) 0.75
Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res (2006) 5.00
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest (2009) 4.12
Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem (2001) 2.91
Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J (2005) 2.82
Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol (2006) 2.70
THE TERMINAL PORTION OF THE PULMONARY ARTERIAL TREE IN PEOPLE NATIVE TO HIGH ALTITUDES. Circulation (1963) 2.35
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J (2002) 2.19
Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats. Circ Res (2007) 2.19
CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med (2002) 2.15
Pulmonary arterial remodeling induced by a Th2 immune response. J Exp Med (2008) 2.08
New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol (1976) 2.06
Pulmonary hypertension in COPD. Eur Respir J (2008) 2.03
Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen (2005) 1.99
Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol (2008) 1.94
Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. Am J Physiol Lung Cell Mol Physiol (2009) 1.81
Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest (1998) 1.72
What controls smooth muscle phenotype? Atherosclerosis (1982) 1.57
Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol (1985) (1987) 1.56
The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J (2007) 1.45
Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension. Chest (2005) 1.45
Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J Physiol (2002) 1.38
Hypoxia and chronic lung disease. J Mol Med (Berl) (2007) 1.36
Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem J (2003) 1.28
Regulation of CX3CL1/fractalkine expression in endothelial cells. J Atheroscler Thromb (2004) 1.19
Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.17
High-altitude disorders: pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest (2010) 1.16
Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling. Int J Exp Pathol (2006) 1.14
Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovasc Res (2007) 1.14
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J (2006) 1.11
Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase. Am J Physiol Lung Cell Mol Physiol (2007) 1.08
Chronic hypoxia: common traits between chronic obstructive pulmonary disease and altitude. Curr Opin Clin Nutr Metab Care (2004) 1.08
Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2005) 1.06
Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells. J Biol Chem (2007) 1.06
Hypoxic vasoconstriction of partial muscular intra-acinar pulmonary arteries in murine precision cut lung slices. Respir Res (2006) 1.03
Rho kinase-mediated vasoconstriction in pulmonary hypertension. Adv Exp Med Biol (2010) 1.02
Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway. Circ Res (2007) 1.02
Autoinhibitory domain fragment of endothelial NOS enhances pulmonary artery vasorelaxation by the NO-cGMP pathway. Am J Physiol Lung Cell Mol Physiol (2004) 1.00
Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. Br J Cancer (2005) 0.97
Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction. FASEB J (2009) 0.94
Endothelial cell influences on vascular smooth muscle phenotype. Annu Rev Physiol (1986) 0.94
Endothelium-derived mediators and hypoxic pulmonary vasoconstriction. Respir Physiol Neurobiol (2002) 0.93
Role of the CX3CL1-CX3CR1 axis in chronic inflammatory lung diseases. Int J Clin Exp Med (2010) 0.93
Syndromes of subacute mountain sickness. High Alt Med Biol (2004) 0.92
Vascular remodeling in neonatal pulmonary hypertension. Role of the smooth muscle cell. Chest (1988) 0.91
Hypoxia-induced pulmonary vascular remodeling: contribution of the adventitial fibroblasts. Physiol Res (2000) 0.90
Nuclear localization of active matrix metalloproteinase-2 in cigarette smoke-exposed apoptotic endothelial cells. Exp Lung Res (2009) 0.90
Role of vascular smooth muscle in the development of high altitude pulmonary hypertension: an interspecies evaluation. High Alt Med Biol (2001) 0.89
Regulation of smooth muscle cell growth by endothelium-derived factors. Tex Heart Inst J (1994) 0.88
Hypoxic pulmonary endothelial cells release a diffusible contractile factor distinct from endothelin. Am J Physiol (1998) 0.87
Circulating endothelial cells: tea leaves for renal disease. Am J Physiol Renal Physiol (2002) 0.85
Synthesis and expression of smooth muscle phenotype markers in primary culture of rabbit aortic smooth muscle cells: influence of seeding density and media and relation to cell contractility. Exp Cell Res (1993) 0.85
Glycosaminoglycan synthesis by smooth muscle cells of differing phenotype and their response to endothelial cell conditioned medium. Atherosclerosis (1990) 0.85
O2 level controls hematopoietic circulating progenitor cells differentiation into endothelial or smooth muscle cells. PLoS One (2009) 0.84
NO upregulation of a cyclic nucleotide-gated channel contributes to calcium elevation in endothelial cells. Am J Physiol Cell Physiol (2002) 0.83
Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation. Am J Physiol Lung Cell Mol Physiol (2011) 0.82
Right ventricular function in scleroderma-related pulmonary hypertension. Rheumatology (Oxford) (2008) 0.82
Hypoxic upregulation of preproendothelin-1 gene expression is associated with protein tyrosine kinase-PI3K signaling in cultured lung vascular endothelial cells. Int J Clin Exp Med (2009) 0.79
Novel peptide for attenuation of hypoxia-induced pulmonary hypertension via modulation of nitric oxide release and phosphodiesterase -5 activity. Peptides (2012) 0.79
Hypoxia induces cell-specific changes in gene expression in vascular wall cells: implications for pulmonary hypertension. Adv Exp Med Biol (1999) 0.78
Down-regulation of mitochondrial cytochrome c oxidase in senescent porcine pulmonary artery endothelial cells. Mech Ageing Dev (2002) 0.78
Hypoxia inhibits proliferation of fetal pulmonary arterial smooth muscle cells in vitro. Pediatr Res (1986) 0.77
[The change of fractalkine in serum and pulmonary arterioles of hypoxic rat]. Sichuan Da Xue Xue Bao Yi Xue Ban (2007) 0.76
[The change of fractalkine in lung tissue of rat with hypoxic pulmonary hypertension]. Sichuan Da Xue Xue Bao Yi Xue Ban (2008) 0.76
A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol (2005) 4.95
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respir Crit Care Med (2014) 2.23
Automated image-based phenotypic analysis in zebrafish embryos. Dev Dyn (2009) 2.11
Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes (2006) 1.96
Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol Aging (2009) 1.72
Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. Am J Respir Crit Care Med (2013) 1.71
Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol (2008) 1.69
Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J Virol (2004) 1.67
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med (2010) 1.64
Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. Gene Expr Patterns (2003) 1.49
Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol (2009) 1.27
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies. Br J Haematol (2010) 1.25
Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages. Immunology (2005) 1.15
Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol (2004) 1.11
Nitric oxide-induced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung endothelial cells. Am J Physiol Cell Physiol (2004) 1.10
Pulmonary hypertension of sickle cell disease beyond classification constraints. J Am Coll Cardiol (2014) 1.09
Discovery of exceptionally efficient catalysts for solvent-free enantioselective hetero-Diels-Alder reaction. J Am Chem Soc (2002) 1.06
Discovery of potent and selective PKC-theta inhibitors. Bioorg Med Chem Lett (2006) 1.05
Severity of influenza A(H1N1) illness and emergence of D225G variant, 2013-14 influenza season, Florida, USA. Emerg Infect Dis (2015) 1.04
Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respir Med (2009) 1.03
Cinchona alkaloid-lewis acid catalyst systems for enantioselective ketene-aldehyde cycloadditions. J Am Chem Soc (2004) 1.02
TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J Neuroimmunol (2002) 1.01
Embolization of hydrophilic catheter coating to the lungs: report of a case mimicking granulomatous vasculitis. Am J Clin Pathol (2009) 1.01
Autoinhibitory domain fragment of endothelial NOS enhances pulmonary artery vasorelaxation by the NO-cGMP pathway. Am J Physiol Lung Cell Mol Physiol (2004) 1.00
Chemokine receptor CXCR3 promotes growth of glioma. Carcinogenesis (2010) 0.99
The facial motor nucleus transcriptional program in response to peripheral nerve injury identifies Hn1 as a regeneration-associated gene. J Neurosci Res (2005) 0.98
CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes. J Neuroimmunol (2008) 0.97
Hypoxic upregulation of arginase II in human lung endothelial cells. Am J Physiol Cell Physiol (2010) 0.97
Senescence-enhanced oxidative stress is associated with deficiency of mitochondrial cytochrome c oxidase in vascular endothelial cells. Mech Ageing Dev (2003) 0.94
Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival. J Heart Lung Transplant (2010) 0.93
Role of the CX3CL1-CX3CR1 axis in chronic inflammatory lung diseases. Int J Clin Exp Med (2010) 0.93
Peptides modified by myristoylation activate eNOS in endothelial cells through Akt phosphorylation. Br J Pharmacol (2006) 0.92
Effect of balloon inflation volume on pulmonary artery occlusion pressure in patients with and without pulmonary hypertension. Chest (2010) 0.91
Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation. Am J Physiol Lung Cell Mol Physiol (2002) 0.90
A model of GAG/MIP-2/CXCR2 interfaces and its functional effects. Biochemistry (2012) 0.89
Value of impedance cardiography in patients studied for pulmonary hypertension. Lung (2011) 0.88
A cellular model to mimic exhaled cigarette smokeinduced lung microvascular endothelial cell injury and death. Int J Clin Exp Med (2010) 0.88
Peptide-stimulation enhances compartmentalization and the catalytic activity of lung endothelial NOS. Cell Physiol Biochem (2009) 0.85
Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? Med Hypotheses (2010) 0.84
In situ hybridization analysis of chemokines and chemokine receptors in the central nervous system. Methods (2003) 0.84
High-content analysis of cancer-cell-specific apoptosis and inhibition of in vivo angiogenesis by synthetic (-)-pironetin and analogs. Chem Biol Drug Des (2009) 0.84
NO upregulation of a cyclic nucleotide-gated channel contributes to calcium elevation in endothelial cells. Am J Physiol Cell Physiol (2002) 0.83
Enhanced apoptosis in prolonged cultures of senescent porcine pulmonary artery endothelial cells. Mech Ageing Dev (2002) 0.83
Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells. Mol Cell Biochem (2003) 0.83
Catalytic asymmetric acyl halide-aldehyde cyclocondensation reactions of substituted ketenes. J Am Chem Soc (2004) 0.83
CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension. PLoS One (2012) 0.83
Proline 326 in the C terminus of murine CX3CR1 prevents G-protein and phosphatidylinositol 3-kinase-dependent stimulation of Akt and extracellular signal-regulated kinase in Chinese hamster ovary cells. J Pharmacol Exp Ther (2005) 0.82
Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells. PLoS One (2013) 0.82
A small-molecule inhibitor, 5'-O-tritylthymidine, targets FAK and Mdm-2 interaction, and blocks breast and colon tumorigenesis in vivo. Anticancer Agents Med Chem (2013) 0.81
Involvement of calpain-calpastatin in cigarette smoke-induced inhibition of lung endothelial nitric oxide synthase. Am J Respir Cell Mol Biol (2005) 0.81
Nitric oxide upregulation of caspase-8 mRNA expression in lung endothelial cells: role of JAK2/STAT-1 signaling. Mol Cell Biochem (2007) 0.80
Role of fractalkine (CX3CL1) in regulating neuron-microglia interactions: development of viral-based CX3CR1 antagonists. Curr Alzheimer Res (2005) 0.80
Enhanced phosphorylation of caveolar PKC-α limits peptide internalization in lung endothelial cells. Mol Cell Biochem (2011) 0.80
Hematopoietic- and neurologic-expressed sequence 1 expression in the murine GL261 and high-grade human gliomas. Pathol Oncol Res (2009) 0.79
Novel peptide for attenuation of hypoxia-induced pulmonary hypertension via modulation of nitric oxide release and phosphodiesterase -5 activity. Peptides (2012) 0.79
Neuroprotective effect of resveratrol prophylaxis on experimental retinal ischemic injury. Exp Eye Res (2012) 0.79
CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5. J Neuroimmunol (2012) 0.79
Hypoxic upregulation of preproendothelin-1 gene expression is associated with protein tyrosine kinase-PI3K signaling in cultured lung vascular endothelial cells. Int J Clin Exp Med (2009) 0.79
Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1. Mol Pharmacol (2004) 0.79
Detection of primary cilia in human glioblastoma. J Neurooncol (2014) 0.79
Priming donor lungs with thioredoxin-1 attenuates acute allograft injury in a rat model of lung transplantation. J Heart Lung Transplant (2008) 0.78
Down-regulation of mitochondrial cytochrome c oxidase in senescent porcine pulmonary artery endothelial cells. Mech Ageing Dev (2002) 0.78
Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest. Differentiation (2009) 0.78
Angiotensin IV enhances phosphorylation of 4EBP1 by multiple signaling events in lung endothelial cells. Mol Cell Biochem (2005) 0.77
Turn-on and label-free fluorescence detection of lead ions based on target-induced G-quadruplex formation. Chem Commun (Camb) (2015) 0.77
Endothelial arginase II responds to pharmacological inhibition by elevation in protein level. Mol Cell Biochem (2010) 0.77
Administration of recombinant human thioredoxin-1 significantly delays and prevents autoimmune diabetes in nonobese diabetic mice through modulation of autoimmunity. Diabetes Metab Res Rev (2011) 0.76
Thioredoxin as a biomarker for graft rejection in lung transplant recipients. Biomarkers (2008) 0.76
Does Admission to the ICU Prevent African American Disparities in Withdrawal of Life-Sustaining Treatment? Crit Care Med (2017) 0.75
Label-free Detection of Zn(2+) Based on G-quadruplex. Anal Sci (2015) 0.75
Pulmonary artery aneurysms. Am J Respir Crit Care Med (2014) 0.75
1870: INTRAVENOUS LIPID EMULSION THERAPY AS AN ANTIDOTE TO LIPOPHILIC MEDICATION INTOXICATION. Crit Care Med (2016) 0.75
Treating pulmonary vascular disease in the developing world: the single step. Chest (2010) 0.75
Cell Penetrating Peptide-Mediated Caveolae-Dependent Activation of Lung Endothelial Nitric Oxide Synthase. Protein Pept Lett (2016) 0.75
Pulmonary arterial hypertension: new treatments are improving outcomes. J Fam Pract (2004) 0.75
Chemokine receptor binding and signal transduction in native cells of the central nervous system. Methods (2003) 0.75
Nitric oxide-modulated marker gene expression of signal transduction pathways in lung endothelial cells. Nitric Oxide (2004) 0.75
667: IDENTIFYING RISK FACTORS FOR INVASIVE CANDIDIASIS IN THE CRITICALLY ILL. Crit Care Med (2016) 0.75